| Symbol | ORGO |
|---|---|
| Name | ORGANOGENESIS HOLDINGS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 85 DAN ROAD, CANTON, Massachusetts, 02021, United States |
| Telephone | +1 781 575-0775 |
| Fax | — |
| — | |
| Website | https://www.organogenesis.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001661181 |
| Description | Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. Additional info from NASDAQ: |
(99% Neutral) ORGANOGENESIS HOLDINGS INC. (ORGO) Announces New Board Appointment
Read moreNew Form ARS - Organogenesis Holdings Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-197380 <b>Size:</b> 712 KB
Read moreNew Form DEF 14A - Organogenesis Holdings Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001193125-26-197357 <b>Size:</b> 3 MB
Read moreOrganogenesis Completes Rolling Submission of Biologics License Application for ReNu®
Read moreGrow Brian 🟡 adjusted position in 0 shares (1 derivative) of Organogenesis Holdings Inc. (ORGO) at $1.24 Transaction Date: Jan 10, 2025 | Filing ID: 000183
Read moreOrganogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
Read moreOrganogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
Read moreOrganogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
Read moreDirector Leibowitz Arthur S 🟢 acquired 5.0K shares of Organogenesis Holdings Inc. (ORGO) at $2.68 Transaction Date: Mar 09, 2026 | Filing ID: 000129
Read moreDirector Driscoll Michael Joseph 🟢 acquired 10.0K shares of Organogenesis Holdings Inc. (ORGO) at $2.67 Transaction Date: Mar 09, 2026 | Filing ID: 000127
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07510412 | Clinical Trial Evaluating NuShield® Plus Standard of Care (SOC) Versus Standard… | Na | Venous Leg Ulcers | Recruiting | 2026-03-18 | 2029-04-01 | ClinicalTrials.gov |
| NCT06618612 | A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracell… | Na | Diabetic Foot Ulcer | Recruiting | 2024-08-19 | 2026-11-19 | ClinicalTrials.gov |
| NCT06000410 | A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients W… | Phase3 | Knee Osteoarthritis | Completed | 2023-09-06 | 2025-11-30 | ClinicalTrials.gov |
| NCT04901013 | Clinical Study Of Affinity Versus SOC In The Management Of VLUs | Na | Venous Leg Ulcer | Unknown | 2021-06-14 | 2023-06-01 | ClinicalTrials.gov |
| NCT04636229 | Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of th… | Phase3 | Knee Osteoarthritis | Completed | 2020-12-14 | 2025-08-19 | ClinicalTrials.gov |
| NCT03855514 | Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabeti… | Na | Diabetic Foot Ulcer | Unknown | 2019-02-08 | 2021-12-30 | ClinicalTrials.gov |
| NCT03828916 | NuShield in Surgical Peroneal Tendon Repair | Na | Tendon Injuries | Unknown | 2019-01-30 | 2021-06-01 | ClinicalTrials.gov |
| NCT03502824 | PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Managem… | Na | Chronic Pressure Ulcers | Terminated | 2018-05-01 | 2021-09-15 | ClinicalTrials.gov |
| NCT03205436 | Affinity Prospective Diabetic Foot Trial Crossover Group | Na | Diabetic Foot Ulcer | Completed | 2017-05-01 | 2019-08-15 | ClinicalTrials.gov |
| NCT03286452 | The RESPOND Registry | — | Partial Thickness Wound | Completed | 2017-02-21 | 2019-01-26 | ClinicalTrials.gov |
| NCT03063099 | ReNu™ Injection to Treat Hip Osteoarthritis Study | Na | Osteoarthritis, Hip | Completed | 2017-02-08 | 2019-06-28 | ClinicalTrials.gov |
| NCT03036878 | ReNu™ Marrow Stimulation Augmentation | Na | Osteochondral Defect | Terminated | 2017-02-07 | 2019-12-06 | ClinicalTrials.gov |
| NCT03070925 | Prospective PuraPly™ AM Case Series Study | — | Pressure Ulcers | Completed | 2016-11-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT03070938 | PuraPly™ Antimicrobial Wound Matrix and Wound Management | — | Pressure Ulcer | Completed | 2016-11-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02982226 | ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis | Na | Fasciitis, Plantar | Unknown | 2016-09-01 | 2021-04-01 | ClinicalTrials.gov |
| NCT02880592 | Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers | Na | Diabetic Foot Ulcers | Completed | 2016-08-01 | 2019-04-01 | ClinicalTrials.gov |
| NCT02837484 | NuTech Affinity™ for the Treatment of Chondral Defects | Na | Chondral Lesions | Unknown | 2016-05-01 | 2020-10-01 | ClinicalTrials.gov |
| NCT02808234 | Study of Nucel for One and Two Level Lumbar Interbody Fusion | Na | Degenerative Disc Disease | Unknown | 2015-12-01 | 2022-12-01 | ClinicalTrials.gov |
| NCT02318511 | An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis | Na | Osteoarthritis | Completed | 2015-06-01 | 2019-02-01 | ClinicalTrials.gov |
| NCT02461641 | NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers | Na | Foot Ulcer, Diabetic | Completed | 2015-03-01 | 2018-10-25 | ClinicalTrials.gov |
| NCT02023372 | Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine | Na | Intervertebral Disc Disease | Completed | 2013-12-01 | 2019-08-16 | ClinicalTrials.gov |
| NCT02011724 | A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful … | Phase4 | Venous Leg Ulcers | Unknown | 2013-11-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01929954 | Safety Study of Gintuit™ in Subjects Requiring Socket Grafting | Phase1 | Edentulous Alveolar Ridge | Terminated | 2013-07-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01619670 | A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects … | Phase4 | Epidermolysis Bullosa | Terminated | 2012-06-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT01623882 | Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wou… | — | Diabetic Foot Ulcer | Withdrawn | 2012-06-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01292122 | Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds | Na | Wounds | Terminated | 2011-06-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01327937 | A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venou… | Phase4 | Venous Ulcer | Completed | 2011-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00909870 | Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers | Phase3 | Venous Leg Ulcer | Completed | 2009-06-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00648674 | A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers | Phase4 | Varicose Ulcer | Withdrawn | 2008-07-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00679081 | A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession R… | Phase1 | Gingival Recession | Terminated | 2008-05-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01134081 | Expression of Angiogenic Biomarkers During Healing of Intra-Oral Soft Tissue En… | Na | Gingival Recession | Completed | 2008-01-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00587223 | Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctiona… | Phase3 | Epidermolysis Bullosa, Junctional | Terminated | 2007-12-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00587587 | A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Exc… | Phase1 | Keloid | Completed | 2007-12-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00587834 | Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration | Phase3 | Gingival Recession | Completed | 2007-10-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT01547962 | A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Atta… | Na | Gingival Recession | Completed | 2005-09-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00512538 | Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers | Phase3 | Diabetic Foot | Terminated | 2000-10-01 | 2002-09-01 | ClinicalTrials.gov |
| NCT01181453 | Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers | Phase3 | Diabetic Foot Ulcer | Completed | 1998-12-01 | 2000-03-01 | ClinicalTrials.gov |
| NCT01181440 | Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers | Phase3 | Diabetic Foot Ulcer | Completed | 1994-09-01 | 1997-01-01 | ClinicalTrials.gov |